Sanjivani Parenteral Limited

Sanjivani Parenteral reported FY26 consolidated PAT of ₹66.94 mn with a 9.60% margin on total income of ₹697.56 mn. The company commenced commercial production at its new IV Fluid Infusion Plant in Pu